170 likes | 769 Views
Human African Trypanosomiasis ( sleeping sickness). Ankita Desai. Kinetoplastids include Sleeping sickness. Approximately 400 million people are at risk of contracting a kinetoplastid disease. Distribution of funds for sleeping sickness. What is HAT?.
E N D
Human African Trypanosomiasis (sleeping sickness) Ankita Desai
Kinetoplastids include Sleeping sickness. Approximately 400 million people are at risk of contracting a kinetoplastid disease.
What is HAT? • Human African Trypanosomiasis = “sleeping sickness” • Early stage vs. late stage
How does one contract HAT? • Tsetse fly is a vector
What causes disease? • Trypanosomabruceigambiense – chronic • Trypanosomabruceirhodesiense – acute; infects cattle and humans
Structure of trypanosome • Nucleus • Kinetoplast (circular DNA inside mitochondrion) • Flagella for movement
Who does it affect? • 36 African countries & ~ 60 million people at risk in 1996. • WHO estimate: b/w 50,000 and 70,000 people are infected.
Who is most susceptible? • At risk if near/on: • forest trails • water collection points in forests • Riverbanks • forest edges surrounding plantations • Flies are attracted by large moving objects and by CO2which is why they often feed on animals and humans • HAT mainly affects the most productive age group (15 to 45 years).
How to detect HAt • Look for inflammation of the brain and its covering, the meninges • Tests include the following: • Blood smear • Cerebrospinal fluid tests • Complete blood count (CBC) • Lymph node aspiration
How can we cure infected persons? • drug treatment • Melarsoprol • Eflornithine (T. gambienseonly) • Nifurtimox (used with Eflornithine)
Problem of relapse and potential drug resistance Melarsoprol relapse rates in second-stage human African trypanosomiasis patients, Equateur Nord Province, 2001–2003
How can the disease be prevented? • WHO suggests supplying people with tsetse fly traps